Johnson & Johnson (JNJ) SEC Filings — 2024
30 SEC filings for Johnson & Johnson (JNJ) in 2024.
Filings
- Johnson & Johnson 13F-HR Filing — 13F-HR · Nov 13, 2024
- Johnson & Johnson SC 13G/A Filing — SC 13G/A · Nov 1, 2024
- Johnson & Johnson Q3 2024 10-Q Filing — 10-Q · Oct 23, 2024
- Johnson & Johnson SC 13G/A Filing — SC 13G/A · Oct 18, 2024
- Johnson & Johnson Files 8-K with Financial Updates — 8-K · Oct 15, 2024
- J&J Files 8-K on Debt Issuances — 8-K · Sep 20, 2024
- J&J Board Changes and Officer Compensation Updates — 8-K · Sep 10, 2024
- J&J Executive Shuffle: New CFO, Medical Devices Chair Departs — 8-K · Aug 26, 2024
- Johnson & Johnson 13F-HR Filing — 13F-HR · Aug 9, 2024
- Johnson & Johnson SC 13G Filing — SC 13G · Jul 30, 2024
- Johnson & Johnson Q2 2024 10-Q Filed — 10-Q · Jul 25, 2024
- J&J Files 8-K on Financials and Debt — 8-K · Jul 17, 2024
- J&J Issues $5B in Notes — 8-K · May 20, 2024
- Johnson & Johnson SC 13G/A Filing — SC 13G/A · May 20, 2024
- J&J Prices $15B in Senior Notes — 8-K · May 17, 2024
- Johnson & Johnson 13F-HR Filing — 13F-HR · May 10, 2024
- Johnson & Johnson Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 1, 2024
- J&J Issues New Debt, Files Financials — 8-K · Apr 29, 2024
- J&J Files 8-K/A Amendment on Debt and Stock — 8-K/A · Apr 16, 2024
- Johnson & Johnson SC 13G Filing — SC 13G · Apr 10, 2024
- Johnson & Johnson DEF 14A Filing — DEF 14A · Mar 13, 2024
- Johnson & Johnson Files 2023 Annual Report on Form 10-K — 10-K · Feb 16, 2024
- Johnson & Johnson 13F-HR Filing — 13F-HR · Feb 14, 2024
- Johnson & Johnson SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- J&J Reports 2.4% Stake in Nanobiotix S.A. as of Dec 31, 2023 — SC 13G/A · Feb 2, 2024
- State Street Corp. Amends J&J Stake Filing as of Dec 31, 2023 — SC 13G/A · Jan 30, 2024
- BlackRock Amends J&J Stake: Passive Ownership Update — SC 13G/A · Jan 26, 2024
- J&J Discloses 182.3M Kenvue Shares Post-Spin-Off — SC 13G · Jan 24, 2024
- J&J Files 8-K on Operations & Financial Condition, Details Notes Due — 8-K · Jan 23, 2024
- J&J to Acquire Ambrx, Boosting Oncology Pipeline with Next-Gen ADCs — DEFA14A · Jan 8, 2024